Setting HbA1c targets for patients with type 2 diabetes

Abstract

Therapeutic strategies to optimize glycaemic control are an important part of clinical decision for management of patients with type 2 diabetes (T2DM). Several guidelines provide a target value of HbA1c for all T2DM patients. However, a "one-size-fits-all" goal might not be the best strategy for all T2DM patients